[Oligomeric procyanidins from hawthorn extract as supplementary therapy in patients with left ventricle systolic dysfunction].
The results of recent studies provide the evidence that extract of hawthorn (Crataegus sp.) may provide benefits in left ventricular systolic dysfunction. The authors present a number of in vitro and in vivo studies in which the influence of this herbal drug on contractility of impaired myocardium has been proved. This kind of supplementary therapy was well tolerated and no interactions with the other compounds for heart failure were reported.
Rechciński
Tomasz
T
II Katedra i Klinika Kardiologii, Uniwersytet Medyczny w Lodzi. Tomasz.2336843@pharmanet.com.pl
Kurpesa
Małgorzata
M
D002317:Cardiovascular Agents / Q000627:therapeutic use*; D027825:Crataegus; D006801:Humans; D008517:Phytotherapy; D010936:Plant Extracts / Q000627:therapeutic use; D044945:Proanthocyanidins / Q000627:therapeutic use; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy*
D002317:Cardiovascular Agents; D010936:Plant Extracts; D044945:Proanthocyanidins